https://synapse.patsnap.com/drug/7bbad061fa7f4e739258605be7d8b3b5
Pexidartinib Hydrochloride - Drug Targets, Indications, Patents - Synapse
Pexidartinib Hydrochloride: a CSF-1R antagonists, FLT3 inhibitors, c-Kit inhibitors Drug, Initially developed by Daiichi Sankyo Co., Ltd., Now, its global...
pexidartinib hydrochloridedrugtargetsindicationspatents